In one phrase, how would you describe your research?
Peptidesa re attractive candidates for use as diagnostic agents, owing to their specificity and excellent pharmacokinetic profiles. Over the last decade, we have devoted our efforts to the development of peptide-based imaging agentsf or positron emission tomography.R adiolabeling of biovectors is challenging and, therefore, we were seekingf or an ideal and universal labeling methodology.M ost of positron-emitting radionuclides (such as 18 F; 68 Ga) have as hort half-life andb iomolecules are often fragile, hampering the use of sophisticated and harsh chemicalr eactions. Ar apid, regioselective,a nd biocompatible incorporation of an imaging probe into the targetingv ector is desired. Thus, we envisioned to develop al abeling methodology in which peptidesa re functionalized with ac lickable handle at an early synthetic stage and then labeled with an imaging probe (i.e. ar adionuclide or af luorogenic dye) by luciferin adduct formation.
What is the most significant result of this study?
We demonstrated that 2-cyanobenzothiazole-bearing imaging reagentsr eact rapidlya nd specifically with peptides containing a1,2-aminothiol moiety under various conditions, even in complex biological medium. This result not only showedt he applicability of our strategy to the labeling of peptides, but also shed light on other potentiald irection, such as the preparation of theranostic agents and pre-targetinga pplicationsi nb iological systems.
What was the inspiration for this cover design? AC hinesei diom said that "push ab oat along with favorable current". The meaning behinds this idiom is that if we do things in the right direction, it will take little effort to achieve our goal. We herein described as imple and efficient strategy for the preparation of labeled peptides, and expected that it will help broaden the applicability of peptides as therapeutics or imaging agents in the future.
